Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0000950170-24-131250

Chief Financial Officer bought 12,829 shares at an average $3.82 ($48,974)

From the SEC's structured data for this filing

Trades in this filing

Hunt Jonathan Robert · Chief Financial Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-11-25 Purchase : show line 1 in the form +400 $3.55 $1,420 36,371 D
2024-11-25 Purchase : show line 2 in the form +29 $3.94 $114 36,400 D
2024-11-25 Purchase : show line 3 in the form +2,400 $3.60 $8,640 38,800 D
2024-11-25 Purchase : show line 4 in the form +10,000 $3.88 $38,800 48,800 D
Open-market purchases · 12,829 sh · avg $3.82 · $48,974
Loading xslF345X05/ownership.xml…